US equities |
META $642.62 ▲+0.00% MU $877.55 ▲+0.00% TSLA $372.22 ▲+0.00% SPCX $147.49 ▲+0.00% NVDA $210.96 ▲+0.00% NU $15.16 ▲+0.00% SNDK $1,238.03 ▲+0.00% NBIS $158.74 ▲+0.00%
FinancialContent

Latest News about CMAX Clinical Research

Recent news which mentions CMAX Clinical Research

Incannex Approved For Bioavailability Clinical Trial For Dronabinol-Based Drug For Treatment Of Obstructive Sleep Apnea
Tickers IXHL
Tags Markets Bellberry Human Research Ethics Committee News
From Benzinga
Nasdaq-listed Bright Minds Closes $4 Million Offering And Begins Dosing In Clinical Trial For Epilepsy
Tickers DRUG
Tags Benzinga Dr/ Revati Shreeniwas Mid Cap
From Benzinga
Incannex Approved To Commence Phase 1 Clinical Trial Of CBD Based Anti-Inflammatory Drug
Tickers IXHL
Tags Dr Mark Bleackley Penny Stocks Benzinga
From Benzinga